Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
“Over the last 12 years, we have watched QSYMIA positively improve quality of life and assist with weight loss, in combination with a healthy diet and consistent exercise. QSYMIA is now approved and ...